Gene Therapy Shows Early Promise as Angelman Syndrome Treatment October 25, 2021 By Janice Warfford Led by Ben Philpot, PhD, and Matt Judson, PhD, the new therapy was generally well-tolerated and prevented key signs of the condition in animal models.聽 Click for article. Filed Under: Categories: Featured News More from Department of Cell Biology and Physiology The unexpected role of a pathogen-sensing immune protein in the brain Lori O鈥橞rien receives an Innovative Science Accelerator Award Dicle Berfin Azizoglu receives a Liver Scholar Research Award
